Cholesterol paradox associated with cerebral ischemic stroke is regardless of lipid-lowering drug use: A cross-sectional cohort study

被引:0
|
作者
Chiu, Pai-Yi [1 ]
机构
[1] Show Chwan Mem Hosp, Neurol, Changhua, Taiwan
关键词
D O I
10.1016/j.jns.2023.122295
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
PV1117
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Cholesterol Paradox in Older People with Type 2 Diabetes Mellitus Regardless of Lipid-Lowering Drug Use: A Cross-Sectional Cohort Study
    Wang, Tzu-Yuan
    Chang, Wei-Lun
    Wei, Cheng-Yu
    Liu, Chung-Hsiang
    Tzeng, Ray-Chang
    Chiu, Pai-Yi
    [J]. NUTRIENTS, 2023, 15 (14)
  • [2] Lipid-lowering agent use at ischemic stroke onset is associated with decreased mortality
    Elkind, MSV
    Flint, AC
    Sciacca, RR
    Sacco, RL
    [J]. NEUROLOGY, 2005, 65 (02) : 253 - 258
  • [3] Prior TIA, lipid-lowering drug use, and physical activity decrease ischemic stroke severity
    Gotkine, Marc
    [J]. NEUROLOGY, 2007, 68 (14) : 1162 - 1162
  • [4] Prior TIA, lipid-lowering drug use, and physical activity decrease ischemic stroke severity
    Deplanque, D.
    Masse, I.
    Lefebvre, C.
    Libersa, C.
    Leys, D.
    Bordet, R.
    [J]. NEUROLOGY, 2006, 67 (08) : 1403 - 1410
  • [5] Association between use of lipid-lowering agents and the risk of the macular degeneration in the participants with dyslipidemia: a cross-sectional study
    Deng, Qiuju
    Liu, Jing
    Wang, Wei
    Wang, Miao
    Ql, Yue
    Sun, Jiayi
    Liu, Jun
    Xie, Wuxiang
    Zhao, Fan
    Li, Yan
    Zhao, Dong
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (16) : C75 - C76
  • [6] Cerebral microbleeds in acute stroke - A cross-sectional study in an Indian cohort
    Hesarur, N.
    Naik, K. R.
    Saroja, A. O.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 513 - 514
  • [7] Therapeutic decisions by number needed to treat and survival gains: a cross-sectional survey of lipid-lowering drug recommendations
    Halvorsen, Peder A.
    Wisloff, Torbjorn F.
    Stovring, Henrik
    Aasland, Olaf
    Kristiansen, Ivar Sonbo
    [J]. BRITISH JOURNAL OF GENERAL PRACTICE, 2011, 61 (589): : e477 - e483
  • [8] Generic atorvastatin is as effective as the brand-name drug (LIPITOR®) in lowering cholesterol levels: A cross-sectional retrospective cohort study
    Loch A.
    Bewersdorf J.P.
    Kofink D.
    Ismail D.
    Abidin I.Z.
    Veriah R.S.
    [J]. BMC Research Notes, 10 (1)
  • [9] Persistence of use of lipid-lowering medications - A cross-national study
    Avorn, J
    Monette, J
    Lacour, A
    Bohn, RL
    Monane, M
    Mogun, H
    LeLorier, J
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (18): : 1458 - 1462
  • [10] Lipid-Lowering Drug Use and Cancer Incidence and Mortality in the ARIC Study
    Marrone, Michael T.
    Mondul, Alison M.
    Prizment, Anna E.
    Couper, David
    Barber, John R.
    Chappidi, Meera R.
    Joshu, Corinne E.
    Platz, Elizabeth A.
    [J]. JNCI CANCER SPECTRUM, 2021, 5 (05)